222 related articles for article (PubMed ID: 2150584)
1. [Synthetic antimalarials and skin].
Ribrioux A
Ann Dermatol Venereol; 1990; 117(12):975-90. PubMed ID: 2150584
[No Abstract] [Full Text] [Related]
2. [Complications with synthetic antimalarials].
Huriez C; Desmons F; Gautier G; Dhellemmes
Lille Med; 1969 Oct; 14(8):851-64. PubMed ID: 4251585
[No Abstract] [Full Text] [Related]
3. Antimalarial medications in dermatology. A review.
Weiss JS
Dermatol Clin; 1991 Apr; 9(2):377-85. PubMed ID: 2060155
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous reactions to rheumatological drugs.
Bailin PL; Matkaluk RM
Clin Rheum Dis; 1982 Aug; 8(2):493-516. PubMed ID: 6216041
[No Abstract] [Full Text] [Related]
5. Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: A retrospective cohort study.
Gonzalez CD; Hansen C; Clarke JT
J Am Acad Dermatol; 2019 Sep; 81(3):859-860. PubMed ID: 31085265
[No Abstract] [Full Text] [Related]
6. Yellow skin discoloration induced by quinacrine in a patient with cutaneous lupus erythematosus.
Vidal D; Altés J; Smandia JA
Actas Dermosifiliogr; 2013 Jan; 104(1):89-90. PubMed ID: 22831783
[No Abstract] [Full Text] [Related]
7. Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.
Mittal L; Zhang L; Feng R; Werth VP
J Am Acad Dermatol; 2018 Jan; 78(1):100-106.e1. PubMed ID: 28989103
[TBL] [Abstract][Full Text] [Related]
8. [Antimalarial drugs in contemporary dermatologic therapy].
Kiedrowicz M; Kacalak-Rzepka A; Bielecka-Grzela S; Maleszka R
Ann Acad Med Stetin; 2011; 57(1):38-44. PubMed ID: 22593989
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroids: a review with emphasis on complications of prolonged systemic therapy.
Truhan AP; Ahmed AR
Ann Allergy; 1989 May; 62(5):375-91. PubMed ID: 2655506
[No Abstract] [Full Text] [Related]
10. [Cutaneous-mucous toxidermia with synthetic antimalarial drugs].
Gillet P; Gillet-Terver MN; Bannwarth B; Trechot P; Pere P; Netter P; Gaucher A
Therapie; 1991; 46(5):391. PubMed ID: 1836681
[No Abstract] [Full Text] [Related]
11. Antimalarial cutaneous side effects: a study in 209 users.
Skare T; Ribeiro CF; Souza FH; Haendchen L; Jordão JM
Cutan Ocul Toxicol; 2011 Mar; 30(1):45-9. PubMed ID: 20950247
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous and ocular changes associated with the use of chlorpromazine.
Wolf ME; Richer S; Berk MA; Mosnaim AD
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of a practical use of synthetic antimalarials in the treatment of rheumatoid polyarthritis].
David-Chaussé J; David-Chaussé F; Picot C; Laporte G; Lagoarde J; Dehais J
Rev Rhum Mal Osteoartic; 1971 Nov; 38(11):681-90. PubMed ID: 5151168
[No Abstract] [Full Text] [Related]
14. The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review.
Wallace DJ
Lupus; 1996 Jun; 5 Suppl 1():S59-64. PubMed ID: 8803913
[TBL] [Abstract][Full Text] [Related]
15. A case of generalized fixed drug eruption due to a piroxicam plaster.
Rho YK; Yoo KH; Kim BJ; Kim MN; Song KY
Clin Exp Dermatol; 2010 Mar; 35(2):204-5. PubMed ID: 20447085
[No Abstract] [Full Text] [Related]
16. Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit.
Wozniacka A; Carter A; McCauliffe DP
Lupus; 2002; 11(2):71-81. PubMed ID: 11958581
[TBL] [Abstract][Full Text] [Related]
17. [Complications of current coronarodilatator agents].
Huriez C; François P; Bergoend H; Thomas P
Lille Med; 1972 May; 17(5):749-54. PubMed ID: 4262479
[No Abstract] [Full Text] [Related]
18. Prolonged pharmacotherapy and the eye. A symposium. The antimalarials and the tranquilizers.
Rubin M
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:67-76. PubMed ID: 4233735
[No Abstract] [Full Text] [Related]
19. Drug reactions. XX. Cutaneous reactions to anticonvulsants.
Almeyda J; Levantine A
Br J Dermatol; 1972 Dec; 87(6):646-9. PubMed ID: 4265242
[No Abstract] [Full Text] [Related]
20. Current treatment of cutaneous lupus erythematosus.
Werth V
Dermatol Online J; 2001 Feb; 7(1):2. PubMed ID: 11328623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
